Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 39, Issue 2, 2012, Pages 221-226

  Deluca, Paolo ^a   Davey, Zoe ^a   Corazza, Ornella ^b   Di Furia, Lucia ^c   Farre, Magi ^d   Flesland, Liv Holmefjord ^e   Mannonen, Miia ^f   Majava, Aino ^f   Peltoniemi, Teuvo ^f   Pasinetti, Manuela ^b   Pezzolesi, Cinzia ^b   Scherbaum, Norbert ^g   Siemann, Holger ^g   Skutle, Arvid ^e   Torrens, Marta ^d   van der Kreeft, Peer ^h   Iversen, Erik ^e   Schifano, Fabrizio ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c Agenzia Regionale Sanitaria   (Italy)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^e The Bergen Clinics Foundation   (Norway)

^f A klinikkasaatio Finland   (Finland)

^g UNIVERSITY OF DUISBURG ESSEN   (Germany)

^h De Sleutel Technische Bedrijfseen heid Provincialaat der Broeders van Liefde   (Belgium)

Author keywords

Emerging trends; Internet; Novel psychoactive substance

Indexed keywords

1,4 BUTANEDIOL; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 3,4 METHYLENEDIOXYPYROVALERONE; 4 ACETOXY N METHYL N ETHYLTRYPTAMINE; 4 BROMO 2,5 DIMETHOXYPHENETHYLAMINE; 4 HYDROXYBUTYRIC ACID; 4' METHYLMETHCATHINONE; 5 METHOXY ALPHA ETHYLTRYPTAMINE; 5,6 METHYLENEDIOXY 2 AMINOINDANE; 5,6 METHYLENEDIOXY 2 INDANAMINE; BENZYDAMINE; BROMO BENZODIFURANYLISOPROPYLAMINE; BUPRENORPHINE; CENTRAL STIMULANT AGENT; DEXANABINOL; EPHEDRINE; GAMMA BUTYROLACTONE; HERKNORIN; METHYLENEDIOXYPYROVALERONE; N [2 (5 METHOXY 1H INDOL 3 YL)ETHYL] N METHYLPROPAN 2 AMINE; NAPHTHALEN 1 YL (1 BUTYLINDOL 3 YL)METHANONE; NAPHYRONE; NOVEL PSYCHOACTIVE SUBSTANCE; PREGABALIN; PSEUDOEPHEDRINE; PSYCHEDELIC AGENT; RECREATIONAL DRUG; SPICE DRUG; UNCLASSIFIED DRUG;

ARTICLE; DRUG MONITORING; DRUG USE; EUROPE; INFORMATION PROCESSING; INTERNET; ONLINE SYSTEM; TREND STUDY;

DRUG MONITORING; EUROPEAN UNION; HUMANS; INTERNET; STREET DRUGS;

EID: 84867015939     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.07.011     Document Type: Article

References (44)

1. ACMD Consideration of the novel psychoactive substances ('legal highs') Available online at. http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/acmdnps2011?view=Binary.
2. Auwärter V., Dresen S., Weinmann W., Müller M., Pütz M., Ferreiros N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?. J Mass Spectrom 2009, 44:832.
3. Brandt S.D., Sumnall H.R., Measham F., Cole J. Analyses of second-generation 'legal highs' in the UK: initial findings. Drug Test Anal 2010, 2(8):377-382.
4. Breyer B.N., Sen S., Aaronson D.S., Stoller M.L., Erickson B.A., Eisenberg M.L. Use of Google Insights for Search to track seasonal and geographic kidney stone incidence in the United States. Urology 2011, 78(2):267-271.
5. Brownstein J.S., Freifeld C.C., Madoff L.C. Digital disease detection - harnessing the web for public health surveillance. N Engl J Med 2009, 360:2153-2157.
6. Brunt T.M., Niesink R.J. The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison. Drug Test Anal 2011, 3:621-634.
7. Carneiro H.A., Mylonakis E. Google Trends: a web-based tool for real-time surveillance of disease outbreaks. Clin Infect Dis 2009, 49(10):1557-1564.
8. Corazza O., Schifano F., Farre M., Deluca P., Davey Z., Drummond C., et al. Designer drugs on the Internet: a phenomenon out-of-control? The emergence of hallucinogenic drug bromo-dragonfly. Curr Clin Pharmacol 2011, 6(2):125-129.
9. Corazza O., Schifano F., Simonato P., Fergus S., Assi S., Stair J., et al. The phenomenon of new drugs on the Internet: a study on the diffusion of the ketamine derivative methoxetamine ('MXE'). Hum Psychopharmacol Clin 2012, 27:145-149.
10. Davey Z., Schifano F., Corazza O., Deluca P. e-Psychonauts: Conducting research in online drug forum communities. J Ment Health 2012, 21:386-394.
11. Deluca P., Schifano F. Searching the Internet for drug-related web sites: analysis of online available information on ecstasy (MDMA). Am J Addict 2007, 16(6):479-483. The Psychonaut 2002 Research Group.
12. EMCDDA Early-warning system on new psychoactive substances - operating guidelines EMCDDA, Europol 2007, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
13. EMCDDA The state of the drugs problem in Europe - Annual report 2009 2009, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
14. EMCDDA The state of the drugs problem in Europe - Annual report 2010 2010, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
15. EMCDDA Risk assessment of new psychoactive substances: operating guidelines 2010, Publications Office of the European Union, Luxembourg.
16. EMCDDA The state of the drugs problem in Europe - Annual report 2011 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
17. EMCDDA Report on the risk assessment of mephedrone in the framework of the Council decision on new psychoactive substances 2011, Publications Office of the European Union, Luxembourg.
18. EMCDDA Europol 2011 Annual Report on the implementation of Council Decision 2005/387/JHA. Lisbon April, 2012, Available online at http://www.emcdda.europa.eu/attachements.cfm/att_155113_EN_EMCDDA-Europol%20Annual%20Report%202011_2012_final.pdf.
19. Erowid EROWID, documenting the complex relationship between humans and psychoactives Retrieved online at. http://www.erowid.org/.
20. Eurobarometer Eurobarometer: youth attitudes on drugs. Analytical report 2011, Flash ED Series #330. Available online at http://ec.europa.eu/public_opinion/flash/fl_330_en.pdf.
21. Google Google Insights for Search Available at. http://www.google.com/insights/search/.
22. Griffiths P., Vingoe L., Hunt N., Mounteney J., Hartnoll R. Drug information systems, early warning, and new drug trends: can drug monitoring systems become more sensitive to emerging trends in drug consumption?. Subst Use Misuse 2000, 35(6-8):811-844.
23. Hillebrand J., Olszewski D., Sedefov R. Legal highs on the Internet. Subst Use Misuse 2010, 45(3):330-340.
24. INCB Report of the International Narcotics Control Board for 2007 2008, United Nations, New York.
25. INCB Report of the International Narcotics Control Board for 2008 2009, United Nations, New York.
26. INCB Report of the International Narcotics Control Board for 2009 2010, United Nations, New York.
27. Jack A. The story of spice. Financial Times, February 13, 2009 2009.
28. Lott J.P., Marlowe D.B., Forman R.F. Availability of websites offering to sell psilocybin spores and psilocybin. J Psychoactive Drugs 2009, 41(3):305-307.
29. Measham F., Moore K., Newcombe R., Welch Z. Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition. Drug Alcohol Today 2010, 10(1):14-21.
30. Mounteney J., Fry C., McKeganey N., Haugland S. Challenges of reliability and validity in the identification and monitoring of emerging drug trends. Subst Use Misuse 2010, 45(1-2):266-287.
31. Psychonaut Web Mapping Research Group Mephedrone report 2009, Institute of Psychiatry, King's College London, London UK.
32. Psychonaut WebMapping Research Group Benzydamine report 2009, Institute of Psychiatry, King's College London, London UK.
33. Psychonaut WebMapping Research Group Spice report 2009, Institute of Psychiatry, King's College London, London UK.
34. Ramsey J., Dargan P.I., Smyllie M., Davies S., Button J., Holt D.W., et al. Buying 'legal' recreational drugs does not mean that you are not breaking the law. QJM 2010, 103:777-783.
35. Scheitle C.P. Google's Insights for search: a note evaluating the use of search engine data in social research. Soc Sci Q 2011, 92:285-295.
36. Schifano F., Deluca P., Baldacchino A., Peltoniemi T., Scherbaum N., Torrens M., et al. Drugs on the web; the Psychonaut 2002 EU project. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30(4):640-646.
37. Schifano F., Corazza O., Deluca P., Davey Z. Psychoactive drug or mystical incense? Overview of the online available information on Spice products. Int J Cult Ment Health 2009, 2(2):137-144. the Psychonaut Web Mapping Group.
38. Schifano F., Deluca P., Agosti L., Martinotti G., Corkery J. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). J Psychopharmacol 2005, 19(6):675-679. The Psychonaut 2002 research group.
39. Schifano F., Albanese A., Fergus S., Stair J.L., Deluca P., Corazza O., et al. Mephedrone (4-methylmethcathinone; 'meow meow'); chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 2011, 214(3):593-602.
40. Schifano F., D'Offizi S., Piccione M., Corazza O., Deluca P., Davey Z., et al. Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother Psychosom 2011, 80:118-122.
41. Schmidt M.M., Sharma A., Schifano F., Feinmann C. 'Legal highs' on the net-evaluation of UK-based websites, products and product information. Forensic Sci Int 2011, 206(1-3):92-97.
42. Townsend M. New drug set to replace banned mephedrone as a 'legal high'. The Observer, Sunday 18 April 2010 2010, http://www.guardian.co.uk/society/2010/apr/18/drug-replace-ban-mephedrone.
43. Winstock A., Mitcheson L., Ramsey J., Davies S., Puchnarewicz M., Marsden J. Mephedrone: use, subjective effects and health risks. Addiction 2011, 106:1991-1996.
44. Wood D.M., Greene S.L., Dargan P.I. Clinical pattern of toxicity associated with novel synthetic cathinone mephedrone. Emerg Med J 2011, 28:280-282.